To minimize this competitive effect we have used the 231 cell line, which lacks classical cadherins [38], and an inducible system that allowed expressing the exogenous E- or P-cadherin to levels similar to the endogenous expression in other breast cancer cell lines. The gene discussed is CDH3; the disease is breast carcinoma.